Eternity Healthcare To Develop A Dual Sensor Noninvasive Saliva-Based Sugar Monitor Device To Test For Diabetes

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHOENIX & VANCOUVER, British Columbia--(BUSINESS WIRE)--Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company specializing in diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood. The technology utilizes an ultra sensitive sugar monitor and an additional sensor for salivary amylase enzyme activity.

Help employers find you! Check out all the jobs and post your resume.